概述| 货号 | AF2677-SP |
| 别名 | CDLS2; DXS423ESMC1 structural maintenance of chromosomes 1-like 1 (yeast); KIAA0178DKFZp686L19178; SB1.8; SB1.8MGC138332; segregation of mitotic chromosomes 1; SMC protein 1A; SMC1 (structural maintenance of chromosomes 1, yeast)-like 1; SMC1 structural maintenance of chromosomes 1-like 1; SMC1A; SMC-1A; SMC-1-alpha; SMC1L1; SMC1SMC1alpha; Smcb; structural maintenance of chromosomes 1A; structural maintenance of chromosomes protein 1A |
全称 | Structural Maintenance of Chromosomes 1 | | 反应种属 | Human |
| 应用 | Western Blot(0.5 µg/mL)
|
| 目标/特异性 | Reconstitute at 0.2 mg/mL in sterile PBS. |
| 使用方法 | Western Blot: 0.5 µg/mL
|
| 来源 | Polyclonal Rabbit IgG |
| 产品组分 | |
性能| 供应商 | R&D Systems |
| Entrez Gene IDs | 8243 (Human); 63996 (Rat) |
| 纯化方式 | Antigen Affinity-purified |
| 免疫原 | Phosphopeptide containing human SMC1 S966 site |
| 生物活性 | Human |
| 标记 | Unconjugated |
| 溶解方法 | Reconstitute at 0.2 mg/mL in sterile PBS. |
| 背景 | The ATM protein kinase phosphorylates SMC1 protein in cells exposed to genotoxins. Overexpression of a non-phosphorylatable mutant of SMC1 subjects a cell to a defective S phase checkpoint and decreased cell survival in response to genotoxic stress. In cells expressing this mutant, BRCA1 and Nbs1 are still phosphorylated, suggesting that SMC1 phosphorylation is downstream of these other phosphorylation events. |
| 运输条件 | Blue Ice |
| 存放说明 | 4℃ |
| 参考文献 | - Cell Cycle
- Cell Structure and Signaling Molecules
- Checkpoint
- DNA Damage and Repair
|
参考图片Detection of Human Phospho-SMC1 (S966) by Western Blot.
Western blot shows lysates of U2OS human osteosarcoma cell line untreated (-) or treated (+) with 1 µM camptothecin (CPT) for 4 hours. PVDF membrane was probed with 0.5 µg/mL Rabbit Anti-Human Phospho-SMC1 (S966) Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2677) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # HAF008). A specific band for Phospho-SMC1 (S966) was detected at approximately ??? kDa (as indicated). The phospho-specificity of this antibody was supported by decreased labeling following treatment with 600 U lambda -phosphatase ( lambda -PPase) for ???time. This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1. |
